VIKING THERAPEUTICS, INC. (VKTX) Operating income 2016–2025
VIKING THERAPEUTICS, INC. (VKTX) annual operating income history from SEC filings — each fiscal year as reported.
-$393.3MFY2025 · since FY2016: -$13.8M → -$393.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$393.3M | -160.6% |
| FY2024 | -$150.9M | -49.7% |
| FY2023 | -$100.8M | -43.3% |
| FY2022 | -$70.4M | -26.4% |
| FY2021 | -$55.7M | -30.5% |
| FY2020 | -$42.7M | -30.5% |
| FY2019 | -$32.7M | -24.9% |
| FY2018 | -$26.2M | -37.2% |
| FY2017 | -$19.1M | -37.7% |
| FY2016 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VKTX financial trends
VKTX RevenueVKTX Net incomeVKTX Net marginVKTX Gross profitVKTX Gross marginVKTX Operating marginVKTX Operating cash flowVKTX Free cash flowVKTX Capital expendituresVKTX Return on equityVKTX Stock buybacksVKTX Dividends paidVKTX Total assetsVKTX Total liabilitiesVKTX Shareholders’ equityVKTX overview →